CoChat

Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression

Open access
Ye, Jiayu, Baer, John M., Faget, Douglas V., Morikis, Vasilios A., Ren, Qihao, Melam, Anupama, Delgado, Ana Paula, Luo, Xianmin, Bagchi, Satarupa Mullick, Belle, Jad I., Campos, Edward, Friedman, Michael, Veis, Deborah J., Knudsen, Erik S., Witkiewicz, Agnieszka K., Powers, Scott, Longmore, Gregory D., DeNardo, David G., Stewart, Sheila A. · 2024 · Cancer Discovery
Cited by 164

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

The tumor microenvironment (TME) profoundly influences tumorigenesis, with gene expression in the breast TME capable of predicting clinical outcomes. The TME is complex and includes distinct cancer-associated fibroblast (CAF) subtypes whose contribution to tumorigenesis remains unclear. Here, we identify a subset of myofibroblast CAFs (myCAF) that are senescent (senCAF) in mouse and human breast tumors. Utilizing the MMTV-PyMT;INK-ATTAC (INK) mouse model, we found that senCAF-secreted extracellular matrix specifically limits natural killer (NK) cell cytotoxicity to promote tumor growth. Genetic or pharmacologic senCAF elimination unleashes NK cell killing, restricting tumor growth. Finally, we show that senCAFs are present in HER2+, ER+, and triple-negative breast cancer and in ductal carcinoma in situ (DCIS) where they predict tumor recurrence. Together, these findings demonstrate that senCAFs are potently tumor promoting and raise the possibility that targeting them by senolytic therapy could restrain breast cancer development. Significance: senCAFs limit NK cell-mediated killing, thereby contributing to breast cancer progression. Thus, targeting senCAFs could be a clinically viable approach to limit tumor progression. See related article by Belle et al., p. 1324.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-23-0426

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 164

Metadata

Authors
Ye, J., Baer, J. M., Faget, D. V., Morikis, V. A., Ren, Q., Melam, A., Delgado, A. P., Luo, X., Bagchi, S. M., Belle, J. I., Campos, E., Friedman, M., Veis, D. J., Knudsen, E. S., Witkiewicz, A. K., Powers, S., Longmore, G. D., DeNardo, D. G., & Stewart, S. A.
Venue
Cancer Discovery
Published
2024-04-29
Volume
14
Issue
7
Pages
1302-1323
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W4395960602
Cited by
164
References
31
FWCI
38.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression. https://app.cochat.ai/papers/10.1158/2159-8290.cd-23-0426
The paper
Ye, J., Baer, J. M., Faget, D. V., Morikis, V. A., Ren, Q., Melam, A., Delgado, A. P., Luo, X., Bagchi, S. M., Belle, J. I., Campos, E., Friedman, M., Veis, D. J., Knudsen, E. S., Witkiewicz, A. K., Powers, S., Longmore, G. D., DeNardo, D. G., & Stewart, S. A. (2024). Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-23-0426

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.